Novartis 13th Drugmaker to Require In-House Claims Data

Novartis logo on building
Novartis this week began requiring all 340B covered entities to submit pharmacy and medical claims data on all dispenses, including at in-house pharmacies.
Switzerland-based Novartis this week began requiring all 340B covered entities to submit pharmacy and medical claims data on all dispenses, [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Major Hospital Trade Group Names Next President and CEO

AHA named Massachusetts Health & Hospital Association President and CEO Steve Walsh as its next president and CEO. (Photo courtesy: AHA)
AHA recently announced that it has selected the head of a Massachusetts hospital trade group to take over as its [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

AbbVie Adds 340B CP Restrictions to New Blood Cancer Drug

AbbVie logo
AbbVie has announced 340B contract pharmacy restrictions for a new federally approved drug used to treat a rare and aggressive form of blood cancer.
AbbVie recently announced 340B contract pharmacy restrictions for its new federally approved drug used to treat Blastic plasmacytoid dendritic cell [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

U.S. House Panel Advances Bill With Hospital 340B Tax Form Reporting

Congressman Murphy during a W&M Committee hearing.
The U.S. House Ways and Means Committee on Wednesday approved U.S. Rep. Gregory Murphy's (R-N.C.) bill to require certain nonprofit hospitals to report new 340B data on federal tax forms.
The U.S. House Ways and Means Committee approved legislation along party lines Wednesday that would require certain nonprofit hospitals to [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Key U.S. House Dem on 340B Loses Primary to Insurgent Challenger

DeGette at hearing
U.S. Rep. Diana DeGette (D-Colo.) lost to Melat Kiros in Colorado’s 1st Congressional District Democratic primary Tuesday.
A Colorado congresswoman, who has played a key role in shaping health and 340B policy on Capitol Hill for nearly [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Cassidy’s 340B Proposal Draws Stakeholder Criticism, Praise 

Cassidy in a hearing
340B stakeholders offered varying reactions to U.S. Sen. Bill Cassidy's (R-La.) 340B draft discussion proposal.
340B stakeholders recently offered mixed reactions to a key—but outgoing—Republican U.S. senator’s sweeping proposal that would allow drug manufacturer 340B [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

BMS Exempts WA From In-House Claims Data Reqs, CP Restrictions

BMS logo sign
Bristol Myers Squibb said its 340B contract pharmacy restrictions and in-house pharmacy claims data requirements no longer apply to Washington state covered entities.
A New Jersey-based drugmaker recently announced that its 340B contract pharmacy restrictions and in-house pharmacy claims data requirements no longer [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

E&C Subcommittee Holds Hearing Today on State Medicaid Fraud Risks

E&C O&I Subcommittee hearing announcement
The U.S. House Energy and Commerce Oversight and Investigations Subcommittee will hold a morning hearing today on “state Medicaid program integrity."
A key U.S. House subcommittee with jurisdiction over the 340B program will hear testimony today from Medicaid directors in four [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Model N Acquires Kalderos, Looks to Expand its 340B Capabilities

Model N Kalderos logo
Model N, an end-to-end commercialization, revenue optimization and compliance platform for life sciences companies, announced it had acquired Kalderos on June 17.
A California-based cloud software company has acquired Kalderos, a health technology company and drug industry vendor that’s been a key [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

BI 12th Drugmaker to Require In-House Claims Data

BI logo
Boehringer Ingelheim will require all 340B covered entities to submit pharmacy and medical claims data on all dispenses, including at in-house pharmacies, beginning July 6.
German drugmaker Boehringer Ingelheim (BI) will require all 340B covered entities to submit pharmacy and medical claims data on all [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live

; ?>